About: Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 2007

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 2007 (uk) article scientifique publié en 2007 (fr) im November 2007 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en payares de 2007 (ast) scientific article published on 01 November 2007 (en)
publication date	wds:Q79914421-EB181CBD-E113-4CF6-8956-B322DD9BBFD3
publication date	2007-11-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q79914421-04C3FAEA-F860-49E1-969E-7494946FDC3E wds:Q79914421-24E7D4D3-3840-444C-B5A4-EE81AEC34BC5 wds:Q79914421-273B2FFD-54B6-45B4-BF5E-211073A12C0B wds:Q79914421-9E8D00D5-3997-40C5-B83D-159CD3D27AD9 wds:Q79914421-A033576C-41C2-456B-94E5-7920048999BB wds:Q79914421-A7EBA94D-9D79-4199-B5AC-DE165D3FA63A wds:Q79914421-B812B9B6-1407-4B8A-AEF9-9A619050F5DD wds:Q79914421-E482DBF6-3D1C-4836-A6E0-C51FD2F9C766 wds:Q79914421-E56DB982-C73A-4E47-BAF4-8939060CB241
author name string	Yves Lévy Jean-François Delfraissy Christine Katlama Patrick Yéni Philippe Lesprit Gaëlle Pédrono ANRS 114-Pneumovac Study Group Nathalie Sarrazin Pascale Morineau
rdfs:label	Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (en) Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (nl)
skos:prefLabel	Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (en) Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (nl)
name	Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (en) Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (nl)
author	wds:Q79914421-46339DA3-F058-45EB-BB6D-2883FA69E7D6 wds:Q79914421-76A23715-34A3-4C1F-AF2C-536070210341 wds:Q79914421-81414BD7-416D-4F60-8BE3-E50748D0F238 wds:Q79914421-AAD1938D-8030-4FC6-B349-3381C8C3373B
author	Cécile Goujard Jean-Michel Molina Geneviève Chêne Pierre-Marie Girard
title	wds:Q79914421-4B3D7398-BEF8-46D6-AD81-DEEFE7ECD995
title	Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults (en)
page(s)	wds:Q79914421-F50BB12F-EFC6-46AA-8D3E-EED169A5DCCA
page(s)	2425-2434
instance of	wds:Q79914421-F100E963-A711-4BE0-B350-12BAFB2B8F88
instance of	scholarly article
PubMed ID	wds:Q79914421-606B9565-FFAD-4519-BD9E-1FB25B227CC8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18025879
PubMed ID	18025879
published in	wds:Q79914421-371B91B4-C153-4D37-9310-369C726DAC28
published in	AIDS
issue	wds:Q79914421-F2C138BE-9295-490C-B8AE-6270EC326485
volume	wds:Q79914421-D86A32D8-8625-4CE2-8080-74F9B2F804D2
issue	18
volume	21
DOI	wds:Q79914421-1C8BF3F0-143D-4367-9906-4744FE823377
DOI	http://dx.doi.org/10.1097/QAD.0B013E3282887E91
DOI	10.1097/QAD.0B013E3282887E91
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79914421
is cites work of	Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy. Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysac Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil Comparison of serologic responses to vaccination with one dose or two doses of 7-valent pneumococcal conjugate vaccine in HIV-infected adult patients. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals Epidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbidities Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant Vaccination in HIV-infected adults Immunization of HIV-infected adult patients - French recommendations. Vaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalities Pneumococcal vaccination in patients with systemic lupus erythematosus: A multicenter placebo-controlled randomized double-blind study Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO). Pneumococcal vaccination in adult solid organ transplant recipients: A review of current evidence Bacterial pneumonia among HIV-infected patients: decreased risk after tobacco smoking cessation. ANRS CO3 Aquitaine Cohort, 2000-2007. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants. Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults Quantitative and Functional Antibody Responses to the 13-Valent Conjugate and/or 23-Valent Purified Polysaccharide Vaccine in Aging HIV-Infected Adults Optimal timing of routine vaccination in HIV-infected persons Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations Polysaccharide responsiveness is not biased by prior pneumococcal-conjugate vaccination Antiretroviral Therapy as Prevention of … Pneumococcal Infections? Long-term immune responses and comparative effectiveness of one or two doses of 7-valent pneumococcal conjugate vaccine (PCV7) in HIV-positive adults in the era of combination antiretroviral therapy. Pneumococcal Vaccination Strategies Among HIV-infected Adult Patients: A Review of the Literature Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software